New Delhi: A unit of Zydus Lifesciences is recalling over 7,000 bottles of Oxybutynin Chloride tablets in the US due to manufacturing issues, according to the US Food and Drug Administr… Read More
Law enforcement and public health officials say a surge in counterfeit versions of drugs that help with weight loss like semaglutide (Ozempic, Wegovy) may be the worst since counterfeit er… Read More
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic product to treat acne in the American market.
The drug firm has received fina… Read More
Nuvama downgrades Zydus to ‘hold’. It says Q1 results are unlikely to be repeated, as exclusivity of epilepsy drug Trokendi is declining and revenue from blood cancer drug Revlim… Read More
In the ever-evolving world of stock market investments, it’s crucial to keep an eye on the latest developments. Here are some key updates on stocks that could impact your investment d… Read More
India’s pharmaceutical industry or top pharma companies of India has experienced remarkable growth and transformation over the years, making it one of the world’s most prominent… Read More
United States: Health insurer Cigna Group said on Thursday it would remove the use of prior authorization or paperwork required to get approval for insurance coverage for 25% of medical serv… Read More
In recent times, the Indian pharmaceuticals industry has surged ahead, making impressive strides in the US market during the first quarter. This growth trend is poised to continue, positioni… Read More
Shares of a Tata Group company gained 2.68% on Friday’s early trades to reach a new record high of ₹ 2027.70 apiece. This happened after the National Stock Exchange (NSE) announc… Read More
In the upcoming week, some of the major companies like Adani Ports, LIC, IRCTC, and Coal India will release their April to June quarter results. The next week is going to be sensiti… Read More
New Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct a Phase III clin… Read More
Zydus Lifesciences announced on June 23 that it will acquire 6.5 per cent equity stake in Mylab Discovery Solutions Limited for ₹106 crore. The deal is a share purchase agree… Read More
NEW DELHI : The Indian pharma market (IPM), which is estimated to have grown 4.5% year-on-year (y-o-y) in June, will find support from strong performance in the US even as domestic… Read More
Nifty50 in Place of HDFC, IT major LTI Mindtree Ltd will replace Housing Development Finance Corporation Ltd in Nifty50 index post due to the junction of the mortgage financier with HDFC Ban… Read More
Zydus Lifesciences is currently trading at Rs. 483.15, up by 0.80 points or 0.17% from its previous closing of Rs. 482.35 on the BSE.
The scrip opened at Rs. 480.35 and has touched a high a… Read More
However, BSE Sensex touched a fresh record high of 63,601.71 on June 22, while Nifty remained just one point away from its record high of 18,887.60. Last week, The 30-share pack BSE Sen… Read More
Stock to Buy
The Nifty faces resistance levels between 18,800 and 18,900, indicating a range where price movement may encounter selling pressure.
On the other hand, if the market turns beari… Read More
Zydus Lifesciences Ltd on Friday reported a 24.48 per cent rise in consolidated net profit at Rs 622.9 crore for the third quarter ended December 31, 2022.
The company had posted a consol… Read More
May 15
Asahi India Glass
Astral
Banswara Syntex
Cantabil Retail India
Century Plyboards (India)
Coromandel International
Emkay Global Financial Services
HI… Read More
Stocks in News today 11th May 20231. Larsen & Toubro: Q4 Revenue at Rs 58.3K cr versus poll of Rs 59.3K cr. PAT at Rs 3.99K cr versus poll of Rs 4.17 cr (Negative). S N Subrahmanyan to b… Read More
New Delhi: Through a recent notification, the National Pharmaceuticals Pricing Authority (NPPA) has fixed the retail of 15 scheduled formulations including Amoxycillin and Potassium Clavulan… Read More
STOCK MARKET UPDATE 1. Infosys Infosys' fourth-quarter results were disappointing due to a 3% sequential decline in constant currency revenue. The working edges were addition… Read More
Zydus Lifesciences is currently trading at Rs. 416.30, up by 4.90 points or 1.19% from its previous closing of Rs. 411.40 on the BSE.
Zydus LifesciencesThe scrip opened at Rs. 411.05 and has… Read More